世界の網膜バイオシミラー市場：市場規模・現状・予測

• 英文タイトル：Global Retinal Biosimilars Market Size, Status and Forecast 2019-2025

• レポートコード：QYR9N7963 • 出版社/出版日：QYResearch / 2019年6月14日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、94ページ • 納品方法：Eメール（受注後２～3営業日） • 産業分類：医療・製薬・バイオ

• 販売価格（消費税別）

Single User	￥577,200 (USD3,900)	▷ お問い合わせ
Enterprise License	￥1,154,400 (USD7,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

当資料は、網膜バイオシミラーのグローバル市場について調査・分析したレポートで、種類別（黄斑変性症の薬、糖尿病性眼疾患治療薬、黄斑パッカー薬、その他）、用途別（病院薬局、小売薬局、オンライン薬局）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場予測、関連企業情報などが含まれています。 ・網膜バイオシミラーの世界市場規模 ・主要企業別市場シェア ・網膜バイオシミラーの世界市場規模：種類別（黄斑変性症の薬、糖尿病性眼疾患治療薬、黄斑パッカー薬、その他） ・網膜バイオシミラーの世界市場規模：用途別（病院薬局、小売薬局、オンライン薬局） ・網膜バイオシミラーのアメリカ市場規模（種類別、用途別） ・網膜バイオシミラーのヨーロッパ市場規模（種類別、用途別） ・網膜バイオシミラーの中国市場規模（種類別、用途別） ・網膜バイオシミラーの日本市場規模（種類別、用途別） ・網膜バイオシミラーの東南アジア市場規模（種類別、用途別） ・網膜バイオシミラーのインド市場規模（種類別、用途別） ・網膜バイオシミラーの中南米市場規模（種類別、用途別） ・主要企業別分析（企業概要、製品動向、販売量など） ・網膜バイオシミラーの世界市場予測（2019年-2025年） ・網膜バイオシミラーの地域別市場予測（2019年-2025年） ...

In 2018, the global Retinal Biosimilars market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.
This report focuses on the global Retinal Biosimilars status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Retinal Biosimilars development in United States, Europe and China.

The key players covered in this study
Novartis (Sandoz)
Shire
Bayer
Genentech
Pfenex
Reliance Life Sciences
Hetero Drugs
Intas Pharmaceuticals
Santo Holding
Regeneron Pharmaceuticals

Market segment by Type, the product can be split into
Macular Degeneration Drugs
Diabetic Eye Disease Drugs
Macular Pucker Drugs
Others

Market segment by Application, split into
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies

Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America

The study objectives of this report are:
To analyze global Retinal Biosimilars status, future forecast, growth opportunity, key market and key players.
To present the Retinal Biosimilars development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of Retinal Biosimilars are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

レポート目次

---

Table of Contents

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Retinal Biosimilars Market Size Growth Rate by Type (2014-2025)
1.4.2 Macular Degeneration Drugs
1.4.3 Diabetic Eye Disease Drugs
1.4.4 Macular Pucker Drugs
1.4.5 Others
1.5 Market by Application
1.5.1 Global Retinal Biosimilars Market Share by Application (2014-2025)
1.5.2 Hospital Pharmacies
1.5.3 Retail Pharmacies
1.5.4 Online Pharmacies
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Retinal Biosimilars Market Size
2.2 Retinal Biosimilars Growth Trends by Regions
2.2.1 Retinal Biosimilars Market Size by Regions (2014-2025)
2.2.2 Retinal Biosimilars Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities

3 Market Share by Key Players
3.1 Retinal Biosimilars Market Size by Manufacturers
3.1.1 Global Retinal Biosimilars Revenue by Manufacturers (2014-2019)
3.1.2 Global Retinal Biosimilars Revenue Market Share by Manufacturers (2014-2019)
3.1.3 Global Retinal Biosimilars Market Concentration Ratio (CR5 and HHI)
3.2 Retinal Biosimilars Key Players Head office and Area Served
3.3 Key Players Retinal Biosimilars Product/Solution/Service
3.4 Date of Enter into Retinal Biosimilars Market
3.5 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type and Application
4.1 Global Retinal Biosimilars Market Size by Type (2014-2019)
4.2 Global Retinal Biosimilars Market Size by Application (2014-2019)

5 United States
5.1 United States Retinal Biosimilars Market Size (2014-2019)
5.2 Retinal Biosimilars Key Players in United States
5.3 United States Retinal Biosimilars Market Size by Type
5.4 United States Retinal Biosimilars Market Size by Application

6 Europe
6.1 Europe Retinal Biosimilars Market Size (2014-2019)
6.2 Retinal Biosimilars Key Players in Europe
6.3 Europe Retinal Biosimilars Market Size by Type
6.4 Europe Retinal Biosimilars Market Size by Application

7 China
7.1 China Retinal Biosimilars Market Size (2014-2019)
7.2 Retinal Biosimilars Key Players in China
7.3 China Retinal Biosimilars Market Size by Type
7.4 China Retinal Biosimilars Market Size by Application

8 Japan
8.1 Japan Retinal Biosimilars Market Size (2014-2019)
8.2 Retinal Biosimilars Key Players in Japan
8.3 Japan Retinal Biosimilars Market Size by Type
8.4 Japan Retinal Biosimilars Market Size by Application

9 Southeast Asia
9.1 Southeast Asia Retinal Biosimilars Market Size (2014-2019)
9.2 Retinal Biosimilars Key Players in Southeast Asia
9.3 Southeast Asia Retinal Biosimilars Market Size by Type
9.4 Southeast Asia Retinal Biosimilars Market Size by Application

10 India
10.1 India Retinal Biosimilars Market Size (2014-2019)
10.2 Retinal Biosimilars Key Players in India
10.3 India Retinal Biosimilars Market Size by Type
10.4 India Retinal Biosimilars Market Size by Application

11 Central & South America
11.1 Central & South America Retinal Biosimilars Market Size (2014-2019)
11.2 Retinal Biosimilars Key Players in Central & South America
11.3 Central & South America Retinal Biosimilars Market Size by Type
11.4 Central & South America Retinal Biosimilars Market Size by Application

12 International Players Profiles
12.1 Novartis (Sandoz)
12.1.1 Novartis (Sandoz) Company Details
12.1.2 Company Description and Business Overview
12.1.3 Retinal Biosimilars Introduction
12.1.4 Novartis (Sandoz) Revenue in Retinal Biosimilars Business (2014-2019)
12.1.5 Novartis (Sandoz) Recent Development
12.2 Shire
12.2.1 Shire Company Details
12.2.2 Company Description and Business Overview
12.2.3 Retinal Biosimilars Introduction
12.2.4 Shire Revenue in Retinal Biosimilars Business (2014-2019)
12.2.5 Shire Recent Development
12.3 Bayer
12.3.1 Bayer Company Details
12.3.2 Company Description and Business Overview
12.3.3 Retinal Biosimilars Introduction
12.3.4 Bayer Revenue in Retinal Biosimilars Business (2014-2019)
12.3.5 Bayer Recent Development
12.4 Genentech
12.4.1 Genentech Company Details
12.4.2 Company Description and Business Overview
12.4.3 Retinal Biosimilars Introduction
12.4.4 Genentech Revenue in Retinal Biosimilars Business (2014-2019)
12.4.5 Genentech Recent Development
12.5 Pfenex
12.5.1 Pfenex Company Details
12.5.2 Company Description and Business Overview
12.5.3 Retinal Biosimilars Introduction
12.5.4 Pfenex Revenue in Retinal Biosimilars Business (2014-2019)
12.5.5 Pfenex Recent Development
12.6 Reliance Life Sciences
12.6.1 Reliance Life Sciences Company Details
12.6.2 Company Description and Business Overview
12.6.3 Retinal Biosimilars Introduction
12.6.4 Reliance Life Sciences Revenue in Retinal Biosimilars Business (2014-2019)
12.6.5 Reliance Life Sciences Recent Development
12.7 Hetero Drugs
12.7.1 Hetero Drugs Company Details
12.7.2 Company Description and Business Overview
12.7.3 Retinal Biosimilars Introduction
12.7.4 Hetero Drugs Revenue in Retinal Biosimilars Business (2014-2019)
12.7.5 Hetero Drugs Recent Development
12.8 Intas Pharmaceuticals
12.8.1 Intas Pharmaceuticals Company Details
12.8.2 Company Description and Business Overview
12.8.3 Retinal Biosimilars Introduction
12.8.4 Intas Pharmaceuticals Revenue in Retinal Biosimilars Business (2014-2019)
12.8.5 Intas Pharmaceuticals Recent Development
12.9 Santo Holding
12.9.1 Santo Holding Company Details
12.9.2 Company Description and Business Overview
12.9.3 Retinal Biosimilars Introduction
12.9.4 Santo Holding Revenue in Retinal Biosimilars Business (2014-2019)
12.9.5 Santo Holding Recent Development
12.10 Regeneron Pharmaceuticals
12.10.1 Regeneron Pharmaceuticals Company Details
12.10.2 Company Description and Business Overview
12.10.3 Retinal Biosimilars Introduction
12.10.4 Regeneron Pharmaceuticals Revenue in Retinal Biosimilars Business (2014-2019)
12.10.5 Regeneron Pharmaceuticals Recent Development

13 Market Forecast 2019-2025
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2019-2025)
13.10 Market Size Forecast by Application (2019-2025)

14 Analyst’s Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details

List of Tables and Figures

Table Retinal Biosimilars Key Market Segments
Table Key Players Retinal Biosimilars Covered
Table Global Retinal Biosimilars Market Size Growth Rate by Type 2014-2025 (Million US$)
Figure Global Retinal Biosimilars Market Size Market Share by Type 2014-2025
Figure Macular Degeneration Drugs Figures
Table Key Players of Macular Degeneration Drugs
Figure Diabetic Eye Disease Drugs Figures
Table Key Players of Diabetic Eye Disease Drugs
Figure Macular Pucker Drugs Figures
Table Key Players of Macular Pucker Drugs
Figure Others Figures
Table Key Players of Others
Table Global Retinal Biosimilars Market Size Growth by Application 2014-2025 (Million US$)
Figure Hospital Pharmacies Case Studies
Figure Retail Pharmacies Case Studies
Figure Online Pharmacies Case Studies
Figure Retinal Biosimilars Report Years Considered
Table Global Retinal Biosimilars Market Size 2014-2025 (Million US$)
Figure Global Retinal Biosimilars Market Size and Growth Rate 2014-2025 (Million US$)
Table Global Retinal Biosimilars Market Size by Regions 2014-2025 (Million US$)
Table Global Retinal Biosimilars Market Size by Regions 2014-2019 (Million US$)
Table Global Retinal Biosimilars Market Share by Regions 2014-2019
Figure Global Retinal Biosimilars Market Share by Regions 2014-2019
Figure Global Retinal Biosimilars Market Share by Regions 2019
Table Market Top Trends
Table Global Retinal Biosimilars Revenue by Manufacturers (2014-2019) (Million US$)
Table Global Retinal Biosimilars Market Share by Manufacturers (2014-2019)
Figure Global Retinal Biosimilars Market Share by Manufacturers in 2018
Table Global Retinal Biosimilars Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Key Players Head office and Area Served
Table Key Players Retinal Biosimilars Product/Solution/Service
Table Date of Enter into Retinal Biosimilars Market
Table Mergers & Acquisitions, Expansion Plans
Table Global Retinal Biosimilars Market Size by Type (2014-2019) (Million US$)
Table Global Retinal Biosimilars Market Size Share by Type (2014-2019)
Figure Global Retinal Biosimilars Market Size Market Share by Type (2014-2019)
Table Global Retinal Biosimilars Market Size by Application (2014-2019) (Million US$)
Table Global Retinal Biosimilars Market Size Share by Application (2014-2019)
Figure Global Retinal Biosimilars Market Size Market Share by Application (2014-2019)
Figure Global Retinal Biosimilars Revenue Market Share by Application in 2018
Figure United States Retinal Biosimilars Market Size 2014-2019 (Million US$)
Table United States Key Players Retinal Biosimilars Revenue (2018-2019) (Million US$)
Table United States Key Players Retinal Biosimilars Market Share (2018-2019)
Table United States Retinal Biosimilars Market Size by Type (2014-2019) (Million US$)
Table United States Retinal Biosimilars Market Share by Type (2014-2019)
Table United States Retinal Biosimilars Market Size by Application (2014-2019) (Million US$)
Table United States Retinal Biosimilars Market Share by Application (2014-2019)
Figure Europe Retinal Biosimilars Market Size 2014-2019 (Million US$)
Table Europe Key Players Retinal Biosimilars Revenue (2018-2019) (Million US$)
Table Europe Key Players Retinal Biosimilars Market Share (2018-2019)
Table Europe Retinal Biosimilars Market Size by Type (2014-2019) (Million US$)
Table Europe Retinal Biosimilars Market Share by Type (2014-2019)
Table Europe Retinal Biosimilars Market Size by Application (2014-2019) (Million US$)
Table Europe Retinal Biosimilars Market Share by Application (2014-2019)
Figure China Retinal Biosimilars Market Size 2014-2019 (Million US$)
Table China Key Players Retinal Biosimilars Revenue (2018-2019) (Million US$)
Table China Key Players Retinal Biosimilars Market Share (2018-2019)
Table China Retinal Biosimilars Market Size by Type (2014-20189) (Million US$)
Table China Retinal Biosimilars Market Share by Type (2014-2019)
Table China Retinal Biosimilars Market Size by Application (2014-2019) (Million US$)
Table China Retinal Biosimilars Market Share by Application (2014-2019)
Figure Japan Retinal Biosimilars Market Size 2014-2019 (Million US$)
Table Japan Key Players Retinal Biosimilars Revenue (2018-2019) (Million US$)
Table Japan Key Players Retinal Biosimilars Market Share (2018-2019)
Table Japan Retinal Biosimilars Market Size by Type (2014-2019) (Million US$)
Table Japan Retinal Biosimilars Market Share by Type (2014-2019)
Table Japan Retinal Biosimilars Market Size by Application (2014-2019) (Million US$)
Table Japan Retinal Biosimilars Market Share by Application (2014-2019)
Figure Southeast Asia Retinal Biosimilars Market Size 2014-2019 (Million US$)
Table Southeast Asia Key Players Retinal Biosimilars Revenue (2018-2019) (Million US$)
Table Southeast Asia Key Players Retinal Biosimilars Market Share (2018-2019)
Table Southeast Asia Retinal Biosimilars Market Size by Type (2014-2019) (Million US$)
Table Southeast Asia Retinal Biosimilars Market Share by Type (2014-2019)
Table Southeast Asia Retinal Biosimilars Market Size by Application (2014-2019) (Million US$)
Table Southeast Asia Retinal Biosimilars Market Share by Application (2014-2019)
Figure India Retinal Biosimilars Market Size 2014-2019 (Million US$)
Table India Key Players Retinal Biosimilars Revenue (2018-2019) (Million US$)
Table India Key Players Retinal Biosimilars Market Share (2018-2019)
Table India Retinal Biosimilars Market Size by Type (2014-2019) (Million US$)
Table India Retinal Biosimilars Market Share by Type (2014-2019)
Table India Retinal Biosimilars Market Size by Application (2014-2019) (Million US$)
Table India Retinal Biosimilars Market Share by Application (2014-2019)
Figure Central & South America Retinal Biosimilars Market Size 2014-2019 (Million US$)
Table Central & South America Key Players Retinal Biosimilars Revenue (2018-2019) (Million US$)
Table Central & South America Key Players Retinal Biosimilars Market Share (2018-2019)
Table Central & South America Retinal Biosimilars Market Size by Type (2014-2019) (Million US$)
Table Central & South America Retinal Biosimilars Market Share by Type (2014-2019)
Table Central & South America Retinal Biosimilars Market Size by Application (2014-2019) (Million US$)
Table Central & South America Retinal Biosimilars Market Share by Application (2014-2019)
Table Novartis (Sandoz) Company Details
Table Novartis (Sandoz) Revenue in Retinal Biosimilars Business (2014-2019) (Million US$)
Figure Novartis (Sandoz) Revenue Growth Rate in Retinal Biosimilars Business (2014-2019)
Table Novartis (Sandoz) Recent Development
Table Shire Company Details
Table Shire Revenue in Retinal Biosimilars Business (2014-2019)(Million US$)
Figure Shire Revenue Growth Rate in Retinal Biosimilars Business (2014-2019)
Table Shire Recent Development
Table Bayer Company Details
Table Bayer Revenue in Retinal Biosimilars Business (2014-2019)(Million US$)
Figure Bayer Revenue Growth Rate in Retinal Biosimilars Business (2014-2019)
Table Bayer Recent Development
Table Genentech Company Details
Table Genentech Revenue in Retinal Biosimilars Business (2014-2019)(Million US$)
Figure Genentech Revenue Growth Rate in Retinal Biosimilars Business (2014-2019)
Table Genentech Recent Development
Table Pfenex Company Details
Table Pfenex Revenue in Retinal Biosimilars Business (2014-2019)(Million US$)
Figure Pfenex Revenue Growth Rate in Retinal Biosimilars Business (2014-2019)
Table Pfenex Recent Development
Table Reliance Life Sciences Company Details
Table Reliance Life Sciences Revenue in Retinal Biosimilars Business (2014-2019)(Million US$)
Figure Reliance Life Sciences Revenue Growth Rate in Retinal Biosimilars Business (2014-2019)
Table Reliance Life Sciences Recent Development
Table Hetero Drugs Company Details
Table Hetero Drugs Revenue in Retinal Biosimilars Business (2014-2019)(Million US$)
Figure Hetero Drugs Revenue Growth Rate in Retinal Biosimilars Business (2014-2019)
Table Hetero Drugs Recent Development
Table Intas Pharmaceuticals Company Details
Table Intas Pharmaceuticals Revenue in Retinal Biosimilars Business (2014-2019)(Million US$)
Figure Intas Pharmaceuticals Revenue Growth Rate in Retinal Biosimilars Business (2014-2019)
Table Intas Pharmaceuticals Recent Development
Table Santo Holding Company Details
Table Santo Holding Revenue in Retinal Biosimilars Business (2014-2019)(Million US$)
Figure Santo Holding Revenue Growth Rate in Retinal Biosimilars Business (2014-2019)
Table Santo Holding Recent Development
Table Regeneron Pharmaceuticals Company Details
Table Regeneron Pharmaceuticals Revenue in Retinal Biosimilars Business (2014-2019)(Million US$)
Figure Regeneron Pharmaceuticals Revenue Growth Rate in Retinal Biosimilars Business (2014-2019)
Table Regeneron Pharmaceuticals Recent Development
Table Global Retinal Biosimilars Market Size by Regions (Million US$) 2019-2025
Figure Global Retinal Biosimilars Market Size Share by Regions (2019-2025)
Figure Global Retinal Biosimilars Market Size Share by Regions in 2025
Figure United States Retinal Biosimilars Market Size Forecast (2019-2025)(Million USD)
Figure Europe Retinal Biosimilars Market Size Forecast (2019-2025)(Million USD)
Figure China Retinal Biosimilars Market Size Forecast (2019-2025)(Million USD)
Figure Japan Retinal Biosimilars Market Size Forecast (2019-2025)(Million USD)
Figure Southeast Asia Retinal Biosimilars Market Size Forecast (2019-2025)(Million USD)
Figure India Retinal Biosimilars Market Size Forecast (2019-2025)(Million USD)
Figure Central & South America Retinal Biosimilars Market Size Forecast (2019-2025)(Million USD)
Table Global Retinal Biosimilars Market Size by Product (2019-2025) (Million US$)
Figure Global Retinal Biosimilars Market Size by Product (2019-2025)
Figure Global Retinal Biosimilars Market Size by Product in 2025
Table Global Retinal Biosimilars Market Size by Application (2019-2025) (Million US$)
Figure Global Retinal Biosimilars Market Size by Application (2019-2025)
Figure Global Retinal Biosimilars Market Size by Application in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

---